Phenytoin-Induced Gingival Over Growth: A Review

Authors Information
Article Notes and Dates
To Cite : Karimzadeh I, Namazi S, Borhani-Haghighi A, Khosropanah H. Phenytoin-Induced Gingival Over Growth: A Review, Soc Pharm J. 2016 ;1(1):e827.
Copyright: Copyright © 2016, Social Pharmacy Journal (SPJ). .
Abstract
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnote
References
  • 1. Kataoka M, Kido J, Shinohara Y, Nagata T. Drug-induced gingival overgrowth--a review. Biol Pharm Bull. 2005; 28(10): 1817-21[PubMed]
  • 2. Nakib N, Ashrafi SS. Drug-induced gingival overgrowth. Dis Mon. 2011; 57(4): 225-30[DOI][PubMed]
  • 3. Brunet L, Miranda J, Roset P, Berini L, Farre M, Mendieta C. Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Eur J Clin Invest. 2001; 31(9): 781-8[PubMed]
  • 4. Meraw SJ, Sheridan PJ. Medically induced gingival hyperplasia. Mayo Clin Proc. 1998; 73(12): 1196-9[DOI][PubMed]
  • 5. Mishra MB, Khan ZY, Mishra S. Gingival overgrowth and drug association: a review. Indian J Med Sci. 2011; 65(2): 73-82[DOI][PubMed]
  • 6. Parwani RN, Parwani SR. Management of phenytoin-induced gingival enlargement: a case report. Gen Dent. 2013; 61(6): 61-7[PubMed]
  • 7. Merritt HH, Putnam TJ. Landmark article Sept 17, 1938: Sodium diphenyl hydantoinate in the treatment of convulsive disorders. By H. Houston Merritt and Tracy J. Putnam. JAMA. 1984; 251(8): 1062-7[PubMed]
  • 8. Steinberg AD. Clinical management of phenytoin-induced gingival overgrowth in handicapped children. Pediat Dentist. 1981; 3: 130-6
  • 9. Karimzadeh I, Namazi S, Vessal G. Erythropoietin as a neuroprotectant: Does phenytoin exert its neuroprotective functions through simulation of erythropoietin production? . Hypotheses Res Med. 2009; 5: 79-91
  • 10.
  • 11. Kimball OP. The Treatment of Epilepsy with Sodium Diphenyl Hydantoinate. Americ Med Associat j. 1939; 112(13): 1244[DOI]
  • 12. Arya R, Gulati S. Phenytoin-induced gingival overgrowth. Acta Neurol Scand. 2012; 125(3): 149-55[DOI][PubMed]
  • 13. Angelopoulos AP, Goaz PW. Incidence of diphenylhydantoin gingival hyperplasia. Oral Patholog. 1972; 34(6): 898-906[DOI]
  • 14. Casetta I, Granieri E, Monetti VC, et al. Phenytoin-Induced Gingival Overgrowth: A Community-Based Cross-Sectional Study in Ferrara, Italy. Neuroepidemiolog J. 1997; 16(6): 296-303[DOI]
  • 15. Mousavi F. Clinical survey of hygienic conditions and changes of the gingival enlargement in epileptic patients under phenytoin treatment. Iran J Public Health. 1991; 20(1-4): 11-8
  • 16. Modeer T, Dahllof G. Development of phenytoin-induced gingival overgrowth in non-institutionalized epileptic children subjected to different plaque control programs. Acta Odontol Scand. 1987; 45(2): 81-5[PubMed]
  • 17. Pihlstrom BL, Carlson JF, Smith QT, Bastien SA, Keenan KM. Prevention of phenytoin associated gingival enlargement--a 15-month longitudinal study. J Periodontol. 1980; 51(6): 311-7[DOI][PubMed]
  • 18. Gautam A, Srivastava R. Esthetic Correction of Phenytoin Induced Gingival Hyperplasia. Health Care. 2013; 28: 31
  • 19. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol. 1992; 19(1): 1-11[PubMed]
  • 20. Dongari-Bagtzoglou A, Research, Science , Therapy Committee, American Academy of Periodontology . Drug-associated gingival enlargement. J Periodontol. 2004; 75(10): 1424-31[DOI][PubMed]
  • 21. Phenytoin-induced gingival overgrowth incidence is dependent upon co-medication. Dental Res J. : 249
  • 22. Kamali F, McLaughlin WS, Ball DE, Seymour RA. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth. J Clin Periodontol. 1999; 26(12): 802-5[PubMed]
  • 23. Kamali F, Ball DE, McLaughlin WS, Seymour RA. Phenytoin metabolism to 5-(4-hydroxyphenyl)-5-phenylhydantoin (HPPH) in man, cat and rat in vitro and in vivo, and susceptibility to phenytoin-induced gingival overgrowth. J Periodontal Res. 1999; 34(3): 145-53[PubMed]
  • 24. Ball DE, McLaughlin WS, Seymour RA, Kamali F. Plasma and saliva concentrations of phenytoin and 5-(4-hydroxyphenyl)-5-phenylhydantoin in relation to the incidence and severity of phenytoin-induced gingival overgrowth in epileptic patients. J Periodontol. 1996; 67(6): 597-602[DOI][PubMed]
  • 25. Guncu GN, Caglayan F, Dincel A, Bozkurt A, Saygi S, Karabulut E. Plasma and gingival crevicular fluid phenytoin concentrations as risk factors for gingival overgrowth. J Periodontol. 2006; 77(12): 2005-10[DOI][PubMed]
  • 26. Seymour RA, Ellis JS, Thomason JM. Drug-induced gingival overgrowth and its management. J R Coll Surg Edinb. 1993; 38(6): 328-32[PubMed]
  • 27. Butler RT, Kalkwarf KL, Kaldahl WB. Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine. J Am Dent Assoc. 1987; 114(1): 56-60[PubMed]
  • 28. Romanos GE, Schroter-Kermani C, Hinz N, Bernimoulin JP. Distribution of fibronectin in healthy, inflamed and drug-induced gingival hyperplasia. J Oral Pathol Med. 1992; 21(6): 256-60[PubMed]
  • 29. Romanos GE, Strub JR, Bernimoulin JP. Immunohistochemical distribution of extracellular matrix proteins as a diagnostic parameter in healthy and diseased gingiva. J Periodontol. 1993; 64(2): 110-9[DOI][PubMed]
  • 30. Vernillo AT, Schwartz NB. The effects of phenytoin (5,5-diphenylhydantoin) on human gingival fibroblasts in culture. J Periodontal Res. 1987; 22(4): 307-12[PubMed]
  • 31. Correa JD, Queiroz-Junior CM, Costa JE, Teixeira AL, Silva TA. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN Dent. 2011; 2011: 497850[DOI][PubMed]
  • 32. Ozaki Y, Kunimatsu K, Hara Y, Kato I, Aoki Y, Yamamoto K, et al. An involvement of granulocyte medullasin in phenytoin-induced gingival overgrowth in rats. Jpn J Pharmacol. 2002; 89(3): 235-41[PubMed]
  • 33. Subramani T, Rathnavelu V, Yeap SK, Alitheen NB. Influence of mast cells in drug-induced gingival overgrowth. Mediat inflam . 2013; 1(3)
  • 34. Hong HH, Uzel MI, Duan C, Sheff MC, Trackman PC. Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest. 1999; 79(12): 1655-67[PubMed]
  • 35. Uzel MI, Kantarci A, Hong HH, Uygur C, Sheff MC, Firatli E, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol. 2001; 72(7): 921-31[DOI][PubMed]
  • 36. Kuru L, Yilmaz S, Kuru B, Kose KN, Noyan U. Expression of growth factors in the gingival crevice fluid of patients with phenytoin-induced gingival enlargement. Arch Oral Biol. 2004; 49(11): 945-50[DOI][PubMed]
  • 37. Yamada H, Nishimura F, Naruishi K, Chou HH, Takashiba S, Albright GM, et al. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts. J Periodontol. 2000; 71(6): 955-60[DOI][PubMed]
  • 38. Maita E, Sato M, Yamaki K. Effect of tranilast on matrix metalloproteinase-1 secretion from human gingival fibroblasts in vitro. J Periodontol. 2004; 75(8): 1054-60[DOI][PubMed]
  • 39. Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006; 11: 1696-701[PubMed]
  • 40. Loffek S, Schilling O, Franzke CW. Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2011; 38(1): 191-208[DOI][PubMed]
  • 41. Soory M, Suchak A. The effects of human mast-cell products and of phenytoin on androgen 5alpha-reductase expression in human gingival fibroblasts. Arch Oral Biol. 2001; 46(9): 847-55[PubMed]
  • 42. Soory M, Suchak A. Effects of alkaline phosphatase and its inhibitor levamisole on the modulation of androgen metabolism by nicotine and minocycline in human gingival and oral periosteal fibroblasts. Arch Oral Biol. 2003; 48(1): 69-76[PubMed]
  • 43. Soory M, Tilakaratne A. Modulation of androgen metabolism by phenytoin, oestradiol and tamoxifen in human gingival fibroblasts. J Clin Periodontol. 2003; 30(6): 556-61[PubMed]
  • 44. Brunius G, Yucel-Lindberg T, Shinoda K, Modeer T. Effect of phenytoin on interleukin-1 beta production in human gingival fibroblasts challenged to tumor necrosis factor alpha in vitro. Eur J Oral Sci. 1996; 104(1): 27-33[PubMed]
  • 45. Finkenzeller G, Totzke F, Fitzke E, Marme D, Dieter P. Over-expression of protein kinase C-alpha enhances platelet-derived growth factor- and phorbol ester- but not calcium ionophore-induced formation of prostaglandins in NIH 3T3 fibroblasts. FEBS Lett. 1993; 321(1): 11-4[PubMed]
  • 46. Maldve RE, Kim Y, Muga SJ, Fischer SM. Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J Lipid Res. 2000; 41(6): 873-81[PubMed]
  • 47. Hall EE. Prevention and treatment considerations in patients with drug-induced gingival enlargement. Curr Opin Periodontol. 1997; 4: 59-63[PubMed]
  • 48. Drew HJ, Vogel RI, Molofsky W, Baker H, Frank O. Effect of folate on phenytoin hyperplasia. J Clin Periodontol. 1987; 14(6): 350-6[PubMed]
  • 49. Prasad VN, Chawla HS, Goyal A, Gauba K, Singhi P. Folic acid and phenytoin induced gingival overgrowth--is there a preventive effect. J Indian Soc Pedod Prev Dent. 2004; 22(2): 82-91[PubMed]
  • 50. Arya R, Gulati S, Kabra M, Sahu JK, Kalra V. Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children. Neurology. 2011; 76(15): 1338-43[DOI][PubMed]
  • 51. Mohan RP, Rastogi K, Bhushan R, Verma S. Phenytoin-induced gingival enlargement: a dental awakening for patients with epilepsy. BMJ Case Rep. 2013; 2013[DOI][PubMed]
  • 52. Lin K, Guilhoto L, Yacubian E. Drug-induced gingival enlargement-Part II. Antiepileptic drugs: not only phenytoin is involved. Epilep Clinic Neurop J. 2007; 13(2): 83-8
  • 53. Camargo PM, Melnick PR, Pirih FQ, Lagos R, Takei HH. Treatment of drug-induced gingival enlargement: aesthetic and functional considerations. Periodontol 2000. 2001; 27: 131-8[PubMed]
  • 54. Rawisandran B. Management of Phenytoin Induced Gingival Overgrowth: A Case Report. J Dental Medic Sci. 2013; 11(6): 19-26[DOI]
  • 55. Al-Ghouti MA, Hawari A, Khraisheh M. A solid-phase extractant based on microemulsion modified date pits for toxic pollutants. J Environ Manage. 2013; 130: 80-9[DOI][PubMed]
  • 56. Ramisetti A, Mutthineni R, Sunder S, Chintala S, Pabolu C. Electrosurgery in management of idiopathic gingival enlargement with chronic periodontitis- A case report. . ISRA Medic J . 2014; 6(1): 38-41
  • 57. Bharti V, Bansal C. Drug-induced gingival overgrowth: The nemesis of gingiva unravelled. J Indian Soc Periodontol. 2013; 17(2): 182-7[DOI][PubMed]
  • 58. Goharkhay K, Moritz A, Wilder-Smith P, Schoop U, Kluger W, Jakolitsch S, et al. Effects on oral soft tissue produced by a diode laser in vitro. Lasers Surg Med. 1999; 25(5): 401-6[PubMed]
  • 59. Amit B, Verma Shalu B. Gingival enlargement induced by anticonvulsants calcium channel blockers and immunosuppressants: A review. IRJP. 2013; 3(7): 116-9
  • 60. Pick RM, Pecaro BC, Silberman CJ. The laser gingivectomy. The use of the CO2 laser for the removal of phenytoin hyperplasia. J Periodontol. 1985; 56(8): 492-6[DOI][PubMed]
  • 61. Roed-Petersen B. The potential use of CO2-laser gingivectomy for phenytoin-induced gingival hyperplasia in mentally retarded patients. J Clin Periodontol. 1993; 20(10): 729-31[PubMed]
  • 62. Rao AS, Walvekar AK, Rao SM, Thomas B. Management of phenytoin induced gingival enlargement associated with cerebral palsy: A challenge to the clinician. Inter J Health Sci. 2013; 2(2): 126
  • 63. Poppell TD, Keeling SD, Collins JF, Hassell TM. Effect of folic acid on recurrence of phenytoin-induced gingival overgrowth following gingivectomy. J Clin Periodontol. 1991; 18(2): 134-9[PubMed]
  • 64. Mohammadi Z. Chlorhexidine gluconate, its properties and applications in endodontics. Iran Endod J. 2008; 2(4): 113-25[PubMed]
  • 65. Inoue F, Harrison JV. Folic acid and phenytoin hyperplasia. Lancet. 1981; 2(8237): 86[PubMed]
  • 66. Backman N, Holm AK, Hanstrom L, Blomquist HK, Heijbel J, Safstrom G. Folate treatment of diphenylhydantoin-induced gingival hyperplasia. Scand J Dent Res. 1989; 97(3): 222-32[PubMed]
  • 67. Brown RS, Di Stanislao PT, Beaver WT, Bottomley WK. The administration of folic acid to institutionalized epileptic adults with phenytoin-induced gingival hyperplasia. A double-blind, randomized, placebo-controlled, parallel study. Oral Surg Oral Med Oral Pathol. 1991; 71(5): 565-8[PubMed]
  • 68. Yerby MS. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia. 2003; 44 Suppl 3: 33-40[PubMed]
  • 69. Norris JF, Cunliffe WJ. Phenytoin-induced gum hypertrophy improved by isotretinoin. Int J Dermatol. 1987; 26(9): 602-3[PubMed]
  • 70. Tokgoz B, Sari HI, Yildiz O, Aslan S, Sipahioglu M, Okten T, et al. Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients. Transplant Proc. 2004; 36(9): 2699-702[DOI][PubMed]
  • 71. Kwun WH, Suh BY, Kwun KB. Effect of azithromycin in the treartment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplant Proc. 2003; 35(1): 311-2[PubMed]
  • 72. Argani H, Pourabbas R, Hassanzadeh D, Masri M, Rahravi H. Treatment of cyclosporine-induced gingival overgrowth with azithromycin-containing toothpaste. Exp Clin Transplant. 2006; 4(1): 420-4[PubMed]
  • 73. Nash MM, Zaltzman JS. Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation. 1998; 65(12): 1611-5[PubMed]
  • 74. Gladue RP, Snider ME. Intracellular accumulation of azithromycin by cultured human fibroblasts. Antimicrob Agents Chemother. 1990; 34(6): 1056-60[PubMed]
  • 75. Namazi S, Borhani Haghighi A, Karimzadeh I. Is oral azithromycin effective for the treatment of phenytoin-induced gingival overgrowth in epileptic patients? Med Hypotheses. 2007; 69(5): 1159-60[DOI][PubMed]
  • 76. Soory M, Suchak A. Phenytoin-mediated androgen metabolism in gingival fibroblasts. Effects of the antiandrogen finasteride and the alkaline phosphatase inhibitor levamisole. . J Clin Periodontol. 2002; 29(10)-60
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Social Pharmacy Journal (SPJ) accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check